Drug research

RP-L102

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype ANCT04069533	RCKT	Phase 2	Unknown	2025-02Estimated
Gene Therapy for Fanconi Anemia, Complementation Group ANCT04248439	RCKT	Phase 2	Active not recruiting	2026-05-05Estimated

RCKTUnknownPrimary completion: 2025-02 · Estimated

Trial details

RCKTActive not recruitingPrimary completion: 2026-05-05 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.